Glaxo announced today it has received approval from the FDA's Center for Biologics Evaluation and Research expanding the indication for FLUARIX to include use in persons 6 months and older.…

During the J.P. Morgan Healthcare Conference, Sage provided an update on its long-term strategy to drive growth at the company. Source: BioSpace

Y Combinator is launching an accelerator fund for early-stage life science companies in the lab phase focused on longevity and aging. Source: BioSpace

Based in Santa Clara, California, CBT Pharma was spun out of Crown Bioscience with four development-stage assets in the oncology space. Source: BioSpace

The EU approval is based on data from three pivotal Phase III studies from the ORCHESTRA trial programme of 2,388 patients who met primary and nearly all key secondary endpoints.…

A look at 6 up and coming blood-testing startups. Source: BioSpace

A federal judge has temporarily blocked the Trump administration's efforts to wind down DACA. Source: BioSpace

The portfolio consists of acute, chronic and oncology products. Source: BioSpace

The company believes the Translarna data is compelling and pointed to the success the drug is having in Europe. Source: BioSpace

Here's a look at the seven best life science companies to work for in 2018. Source: BioSpace